MIM
ETNB

MetLife Investment Management’s 89bio ETNB Stock Holding History

MetLife Investment Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-74,661
Closed -$1.1M – 2829
2025
Q3 		$1.1M Hold
74,661
– – 0.01% 1387
2025
Q2 		$733K Buy
74,661
+8,626
+13% +$71.4K ﹤0.01% 1475
2025
Q1 		$480K Buy
66,035
+15,770
+31% +$138K ﹤0.01% 1750
2024
Q4 		$393K Buy
50,265
+5,033
+11% +$41.4K ﹤0.01% 1923
2024
Q3 		$335K Buy
45,232
+457
+1% +$3.84K ﹤0.01% 1996
2024
Q2 		$359K Buy
44,775
+4,178
+10% +$37.3K ﹤0.01% 1909
2024
Q1 		$473K Buy
40,597
+7,978
+24% +$88.3K ﹤0.01% 1708
2023
Q4 		$364K Hold
32,619
– – ﹤0.01% 1873
2023
Q3 		$504K Hold
32,619
– – ﹤0.01% 1635
2023
Q2 		$618K Buy
+32,619
New +$573K ﹤0.01% 1559

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MetLife Investment Management's ETNB Position: Q4 2025 in Review

MetLife Investment Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 74,661 shares — an estimated $1.1M sold.

MetLife Investment Management first reported a position in ETNB in Q2 2023 and held it in 10 quarters. The position peaked at $1.1M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • MetLife Investment Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • MetLife Investment Management sold 74,661 89bio shares in Q4 2025, an estimated $1.1M.
  • MetLife Investment Management first reported a position in 89bio in Q2 2023 and held it in 10 quarters.
  • MetLife Investment Management's 89bio position peaked at $1.1M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.